Form 4: Ventas Director Matthew Lustig Acquires Additional Shares Through Dividend Equivalent Programs

Director Matthew Lustig increased his holdings in Ventas, Inc. through dividend equivalents credited under the company's deferral plans.

Summary

• On April 17, 2025, Matthew J. Lustig, a director of Ventas, Inc., acquired additional shares of common stock through dividend equivalents.
• These shares were granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan and the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program.
• Lustig acquired 246.165 shares at a price of $67.93 under the Cash Compensation Deferral Plan.
• Additionally, he acquired 55.23 shares at the same price under the Equity Award Deferral Program.
• Following these transactions, Lustig beneficially owns 87,020.313 shares of Ventas, Inc. common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a routine transaction related to director compensation and dividend equivalents, with no explicit positive or negative implications.

Positives

• The director's increased stake in the company could be seen as a positive signal, indicating confidence in Ventas, Inc.'s future performance.

Industry Context

Directors receiving stock through dividend equivalent programs is a common practice in publicly traded companies, aligning their interests with those of shareholders.

Comparison to Industry Standards

• Comparing Ventas' director compensation and stock ownership with peers like Welltower (WELL) and Healthpeak Properties (PEAK) would provide context on whether Lustig's holdings are typical for a director in the healthcare REIT sector.
• Analyzing the prevalence of dividend equivalent programs among these companies can further benchmark Ventas' practices.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.

Key Dates

Keywords

Ventas, Director, Matthew Lustig, Stock Acquisition, Dividend Equivalents, Deferral Plan, Equity Award, Beneficial Ownership, Form 4